Dr. Elizabeth Gilman, an Assistant Professor of Medicine in the Breast Diagnostic Clinic at Mayo Clinic in Rochester, MN, discusses her article appearing in the April 2021 issue of Mayo Clinic Proceedings, where she offers clinicians insights into identifying patients at high risk for invasive breast cancer and includes guidance on endocrine therapies which have been shown to be effective preventative treatments. She notes clinicians can learn much about their patients through reviewal of family histories and engaging in discussions that promote shared decision-making. Dr. Gilman also reviews the helpful tables that are included in the article that compare the available risk-reducing treatments. Available at: [ Ссылка ]
